KCAC Position Statements — Global Kratom Coalition™

KCAC Position Statements

Enhancing Safety for Kratom Consumers

Registration and Enforcing Registration of Kratom Products

Proper Labeling of Kratom Products

The Status and Legality of 7 (7-Hydroxymitragynine) Products

Kratom Use in Children

Non-Swallowed Formulations of Kratom Products

Protecting Consumers from Concentrated Synthetic Alkaloids

CE Program: University of Connecticut School of Pharmacy

Fact check on the claim that 7 is responsible for the reduction in Fentanyl overdose death

KCAC Position Statement About HARTs New “Animal Safety” Study

Have “7” Products with 7-Hydroxymitragynine (7-OH) Been Proven to Be Safe?

Why Poison Control Center Mortality Data Cannot Accurately Reflect 7-OH Risk

Fact Check on Kratom Benefits Due to 7-OH

Concentrated Synthetic 7-Hydroxymitragynine (7-OH) Products

KCAC Position Statement Top 10 Reasons Natural Kratom Leaf is Not a Public Health Concern 2025